Stock Updates

Today’s Top Gainers in the Market Alexion Pharmaceuticals, Inc. (NASDAQ:ALXN) from Healthcare

Today’s top gainers include the company Alexion Pharmaceuticals, Inc. (NASDAQ:ALXN) which is in the industry Biotechnology, gaining -2.13% today. In the last week its performance is -5.08%, and 11.28% for the past quarter. Currently, Alexion Pharmaceuticals, Inc., ALXN has a target price of 164.06, so today’s gain of -2.13% is a significant step towards its target price. The GAP today is therefore 0.00%.

Alexion Pharmaceuticals, Inc. (NASDAQ:ALXN), has a market cap of 27921.37, and is based in USA. Insider ownership is at 0.50%, and institutional ownership is 98.30%.

At the current price of 124.51, it has a dividend yield of *TBA, and its target price is 164.06. This is with a profit margin of 3.20%, and total debt/equity of 0.4. Alexion Pharmaceuticals, Inc. (NASDAQ:ALXN) has a P/E of 315.22, as well as a forward P/E of 21.32.

With a current EPS of 0.4, and a forecasted EPS growth for next year at 25.98%,Alexion Pharmaceuticals, Inc. (NASDAQ:ALXN) has had a EPS growth for the past five years at 5.10%. For the next five years EPS growth is projected to be 18.28%.

Performance for the year is -16.58%. Since its IPO date on 2/28/1996, the total performance to date is -34.73%.

Volume today for Alexion Pharmaceuticals, Inc. (NASDAQ:ALXN), is 1484700, while its average volume is 1622.48. Whilst the total gain today was -2.13%, it did have a day high of -10.04%.

Volatility for this week has been at 3.11%, and 2.92% for the month. The 52-week low for Alexion Pharmaceuticals, Inc., ALXN has been 12.62%, while the 52-week-high has reached -35.64%.

Looking at its return of investments, which is 1.60%, and its return on assets is 0.70%. Alexion Pharmaceuticals, Inc. (NASDAQ:ALXN) has an operating margin of 21.70%. With a sales growth of 18.40% quarter over quarter. Bearing in mind that Alexion Pharmaceuticals, Inc., ALXN is in the sector Healthcare, its long-term debt/equity is 0.39, and has a current ratio of 3.6 and 3.1 for quick ratio.

So what is the value of Alexion Pharmaceuticals, Inc.? Well its PEG is 17.24, and the P/S is 9.9, along with a P/B of 3.4. Meanwhile it has a p/cash of 23.66.

Disclaimer: Remember there is a risk to your investment, this is not a recommendation, nor personal advice, never invest more than you are able too loose.

About the author

Tony Dabbs

Leave a Comment